Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

BACKGROUND: Median survival of non-small cell lung cancer (NSCLC) patients with brain metastases is poor. We examined concurrent erlotinib and whole brain radiotherapy (WBRT) followed by maintenance erlotinib in patients with untreated brain metastases, given the potential radiosensitizing propertie...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Lee, Siow Ming, Lewanski, Conrad R., Counsell, Nicholas, Ottensmeier, Christian, Bates, Andrew, Patel, Nirali, Wadsworth, Christina, Ngai, Yenting, Hackshaw, Allan, Faivre-Finn, Corinne
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112798/
https://ncbi.nlm.nih.gov/pubmed/25031274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju151
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki